|
|
|
|
||
|
||
|
Vol. 8, Nos. 1-50, pp. 1-1650 Jan. 1 -- Dec. 31, 2010 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Baker v. AstraZeneca Pharms. LP (N.J. Super. Ct.), 387
Baldino; King v. (3d Cir.), 1622 Barcelo; U.S. v. (S.D. Fla.), 1108 Barr Labs. Inc.; AstraZeneca Pharms. LP v. (D. Del.), 643 Barr Labs. Inc.; Bayer Schering Pharma AG v. (U.S., rev den), 587 Barr Labs. Inc.; Boehringer Ingelheim Intl. GmbH v. (Fed. Cir.), 120; 619 Barr Labs. Inc.; Cancer Research Tech. Ltd. v. (D. Del.), 385; (Fed. Cir.), 385; 1457 Barr Labs. Inc.; Endo Pharms. Inc. v. (D.N.J.), 516 Barr Labs. Inc.; Mitsubishi Chem. Corp. v. (S.D.N.Y.), 810 Barr Pharms.; Sepracor Inc. v. (E.D.N.C.), 1617 Bartlett v. Mutual Pharm. Co. (D.N.H.), 986; 1183 Baumgardner v. Wyeth Pharms. Inc. (E.D. Pa.), 1184 Baxter Healthcare Corp.; Robinson v. (E.D. Tex.), 91 Baycol Cases I and II (Cal.), 275 Bayer AG; Arkansas Carpenters Health and Welfare Fund v. (2d Cir.), 675; 853; 1130 Bayer AG; De Bouse v. (Ill.), 8 Bayer AG; Flesner v. (8th Cir.), 354 Bayer AG; Louisiana Wholesale Drug Co. v. (U.S., rev sought), 1579 Bayer Corp.; Anderson v. (7th Cir.), 888 Bayer Corp.; Andrews v. (N.D. Cal.), 131 Bayer Corp.; Gilmore v. (S.D. Ill.), 12 Bayer Corp.; Mays v. (8th Cir.), 61 Bayer Corp.; Mississippi v. (Miss.), 517 Bayer Corp.; Smith v. (U.S., rev grant), 1273 Bayer Healthcare LLC; Novartis Vaccines and Diagnostics Inc. v. (E.D. Tex.), 273 Bayer Healthcare Pharms. v. Biogen Idec Inc. (D.N.J.), 749 Bayer Pharms. Corp.; King v. (W.D. La.), 556 Bayer Schera Pharma AG v. Sandoz Inc. (S.D.N.Y.), 1136; 1270 Bayer Schering v. Attorney Gen. of Canada (Canada, Fed. Ct. App.), 1417 Bayer Schering Pharma AG v. Barr Labs. Inc. (U.S., rev den), 587 Bayer Schering Pharma AG v. Lupin Ltd. (D. Md.), 552 Bayer Schering Pharma AG v. Sandoz Inc. (S.D.N.Y.), 456 Bayer Schering Pharma AG v. Teva Pharm. Indus. Ltd. (D. Del.), 713; 886 Bayer Schering Pharma AG v. Teva Pharm. Indus. Ltd. (D. Nev.), 886; 1613 Bayer Schering Pharma AG v. Teva Pharms. USA Inc. (N.D. Ill.), 814; 886 Bayer Schering Pharma AG; Teva Pharms. USA Inc. v. (S.D.N.Y.), 713; 886; 1613 Beilfuss, U.S. ex rel. v. Allergan Inc. (N.D. Ga.), 1131 Benhamou; SEC v. (S.D.N.Y.), 1401 Benhamou; U.S. v. (S.D.N.Y.), 1401 Bessemer v. Novartis Pharms. Corp. (N.J. Super. Ct.), 1310 Beylin v. Wyeth Inc. (D. Minn.), 1219 Bilski v. Kappos (U.S.), 847 Bioenvision; Vladimir v. (2d Cir.), 492 Biogen Idec Inc.; Bayer Healthcare Pharms. v. (D.N.J.), 749 Biogen Idec Inc.; Classen Immunotherapies v. (U.S., rem), 851 Biogen Idec Inc. v. EMD Serono Inc. (D.N.J.), 749 Biogen Idec Inc. v. GlaxoSmithKline LLC (S.D. Cal.), 416 Biovail Corp.; SEC v. (S.D.N.Y.), 817 Biovail Labs. Intl. SRL v. Watson Pharms. Inc. (D. Del.), 232 Bisaro; FTC v. (D.D.C.), 942; 979; 1080; 1553 Blue Cross and Blue Shield of Ala.; Wyeth Inc. v. (Ala.), 89 Blue Cross Blue Shield of Mass.; AstraZeneca Pharms. LP v. (U.S., dism), 1272 Board of Trustees of the Leland Stanford Junior Univ. v. Roche Molecular Sys. Inc. (U.S., rev grant), 1394 Boehringer Ingelheim Intl. GmbH v. Barr Labs. Inc. (Fed. Cir.), 120; 619 Boehringer Ingelheim Intl. GmbH; Mylan Inc. v. (W.D. Pa.), 413 Boehringer Ingelheim Intl. GmbH v. Mylan Pharms. Inc. (D.N.J.), 1106 Boehringer Ingelheim Intl. GmbH; Sandoz Inc. v. (M.D. Fla.), 1020 Boehringer Ingelheim Pharms. Inc.; Gazal v. (D. Minn.), 1185 Boles v. Merck & Co. (S.D.N.Y.), 421; 855; 1344 Bone Care Intl. LLC v. Pentech Pharms. Inc. (N.D. Ill.), 647 Bradford; U.S. v. (D. Kan.), 1222 Braintree Labs.; Rochester Drug Coop. v. (D. Del.), 678 Breg Inc.; Pavelko v. (D. Colo.), 1365 Bristol-Myers Squibb Co.; AIDS Healthcare Found. v. (C.D. Cal.), 1502 Bristol-Myers Squibb Co. v. Mylan Pharms. Inc. (D. Del.), 123 Bruesewitz v. Wyeth Inc. (U.S., rev grant), 314 Budeprion XL Mktg. & Sales Litig., In re (E.D. Pa.), 745; 854 Burrell v. AstraZeneca Pharms. LP (Del. Super. Ct.), 1249 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
